(Q42515629)

1 November 2017

title

Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas (English)

1 reference

1 November 2017

0 references

Fujitani S

1

1 reference

1 November 2017

Ikenoue T

2

1 reference

1 November 2017

Akiyoshi M

3

1 reference

1 November 2017

Maki T

4

1 reference

1 November 2017

Yada T

5

1 reference

1 November 2017

publication date

1 February 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

45

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

184-189

1 reference

The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of langerhans and isolated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Islet somatostatin--microvascular, paracrine, and pulsatile regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Somatostatin. Its possible role in carbohydrate homeostasis and the treatment of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Diabetes (III): New Hormones Promise More Effective Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

EFFECTS OF CARBOHYDRATES ON SECRETION OF INSULIN FROM ISOLATED RAT PANCREAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Two types of Ca channel in rat pancreatic ?-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic B-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Electrophysiology of the pancreatic beta-cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Modulation by somatostatin of nerve-mediated activation of glycogenolysis in the perfused rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Somatostatin-28 does not regulate islet function in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Sensitivity of rat pancreatic A and B cells to somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Pancreatic and extrapancreatic sulfonylurea receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

The non-sulfonylurea moiety of gliquidone mimics the effects of the parent molecule on pancreatic B-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

The Role of Sodium in Somatostatin Secretion: Evidence for the Involvement of Na+Channels in the Release Mechanism*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990051-7

10.1016/S0026-0495(96)90051-7

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference